Respiratory Syncytial Virus (RSV) Infection News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

How to develop vaccines and medicines that prevent and treat respiratory syncytial virus (RSV) infection - EU News



How to develop vaccines and medicines that prevent and treat respiratory syncytial virus (RSV) infection 
EU News
RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover within one to two weeks, but RSV can be serious, especially in infants and older adults. It is the most common cause of lower respiratory tract ...

and more » 


Respiratory Syncytial Virus {RSV} Infections Pharmaceutical and Healthcare disease Pipeline Review, H2 2017 ... - Medgadget (blog)



Medgadget (blog)
 
Respiratory Syncytial Virus {RSV} Infections Pharmaceutical and Healthcare disease Pipeline Review, H2 2017 ... 
Medgadget (blog)
A new independent 255 page research with title 'Respiratory Syncytial Virus {RSV} Infections ? Pipeline Review, H2 2017' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions and ...
Pediatric Respiratory Syncytial Virus Infection Market Growth Opportunities Report 2026 LANews By Abhishek Budholiya (press release) (blog)

all 2 news articles » 


RSV recommendations unchanged after review of new data - AAP News



RSV recommendations unchanged after review of new data 
AAP News
For infants and young children at increased risk of respiratory syncytial virus (RSV) infection, monthly prophylaxis with palivizumab may be considered. In August 2014, the Academy published the most recent guidelines to assist with identification of ...
Highly contagious RSV can be dangerous for infants WATE 6 On Your Side

all 2 news articles » 


EMA Drafts Guideline on RSV Treatments and Vaccines - Regulatory Focus



Regulatory Focus
 
EMA Drafts Guideline on RSV Treatments and Vaccines 
Regulatory Focus
... (EMA) on Tuesday released for consultation a new guideline to help companies develop new medicines, direct-acting antiviral agents, monoclonal antibodies and vaccines to treat and prevent infections caused by the respiratory syncytial virus (RSV).

 


Life Lessons: Preventing RSV - WFMZ Allentown



WFMZ Allentown
 
Life Lessons: Preventing RSV 
WFMZ Allentown
She took her baby to Nationwide Children's Hospital where he was diagnosed with respiratory syncytial virus, more commonly known as RSV. Adam spent four days inpatient receiving oxygen, IV fluids and breathing treatments that ... ?By age two, 90 to 100 ...

 


The Health Department Hosts the Last Drive-Up Flu Clinic - EverythingLubbock.com



EverythingLubbock.com
 
The Health Department Hosts the Last Drive-Up Flu Clinic 
EverythingLubbock.com
"We've had the cases of RSV, Respiratory Syncytial Virus, and things like that. So usually when these cases start coming up, the flu follows within a week or two," says Dr. Nawal Zeuitoni, Pediatrician. The flu is a viral infection that attacks the ...

and more » 


ADMA Biologics (ADMA) Reports Newly Issued US Patent for Immunotherapeutic Compositions - StreetInsider.com



ADMA Biologics (ADMA) Reports Newly Issued US Patent for Immunotherapeutic Compositions 
StreetInsider.com
Mr. Grossman continued, ?Not to be overshadowed, however, is the fact that we remain on track to one day provide a new avenue for treating patients at risk for or suffering from infection by RSV, or other respiratory pathogens while concurrently ...

and more » 


RSV is common but little-known, and dangerous for babies - The Columbus Dispatch



The Columbus Dispatch
 
RSV is common but little-known, and dangerous for babies 
The Columbus Dispatch
They were given a pamphlet on respiratory syncytial virus, or RSV, and told to keep a close eye on Addy. ... Those symptoms can linger for those who become severely ill, and such children might be susceptible to recurrent infections for years, Ramilo said.

and more » 


Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease, study finds - Science Daily



Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease, study finds 
Science Daily
This study offers a solution to the formalin inactivated respiratory syncytial virus (FI-RSV) vaccine that did not protect children, but rather caused severe respiratory illness, vaccine-enhanced respiratory disease (ERD), after infection with RSV. The ...

and more » 


Novavax Inc (NASDAQ:NVAX) Among Today's Biggest Gainers ? Up by 6.50% - HugoPress



Analyst Ratings
 
Novavax Inc (NASDAQ:NVAX) Among Today's Biggest Gainers ? Up by 6.50% 
HugoPress
The Business's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Business's lead ...
7 Stocks of the Month: December Edition Zacks.com
SEC FORM 4 - SEC.gov SEC.gov
SEC FORM 4 - SEC.gov SEC.gov

all 39 news articles »